Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2022
Huoxiang Zhengqi Water flagged by NMPA over excessive methanol
In August 2022, the National Medical Products Administration notified 20 batches of drugs as noncompliant, including three batches of Huoxiang Zhengqi Water from Taiji Group subsidiary Nanchong Pharmaceutical with methanol levels exceeding the limit. Taiji Group apologized and recalled 15,677 boxes from the unsold portion; drug regulators required a case investigation.
2022
Taiji Group recalls unsold Huoxiang Zhengqi Water
Recall announced
After testing found that methanol levels in three batches of Huoxiang Zhengqi Water produced by its subsidiary Nanchong Pharmaceutical did not meet requirements, Taiji Group said the subsidiary had recalled all 15,677 unsold boxes of the affected products. Taiji Group apologized and said it had ordered the subsidiary to investigate and rectify the matter.
Company response
Recall — 南充制药
南充制药对上述批号产品未销售部分15677盒已按程序全部召回。
Apology — 太极集团
公司就此次事件造成的不良影响真诚致歉。
Investigation — 太极集团
已责成该公司认真核查整改
Source excerpt
2022年2月和2022年3月,浙江省食品药品检验研究院、四川省药品检验研究院(四川省医疗器械检测中心)共抽检全资子公司南充制药三批藿香正气水样品,交由江西省药品检验检测研究院检测,检验结果为甲醇量指标不符合规定。
南充制药对上述批号产品未销售部分15677盒已按程序全部召回。
2017
Taiji Group's Chongqing TCM No.2 Factory penalized over substandard Xiao'er Kechuanling Granules
CNR disclosed the Chongqing Food and Drug Administration's fourth enforcement information for 2016: batch 1401003 of Xiao'er Kechuanling Granules produced by Chongqing Traditional Chinese Medicine No.2 Factory had properties that did not meet specifications, was deemed an inferior drug, and illegal gains were confiscated. The incident was limited to the notified batch. Progress: media reported the regulatory enforcement result. Subject: Taiji Group Chongqing Traditional Chinese Medicine No.2 Factory Co., Ltd. Scope: products and administrative enforcement events of its Taiji Group Chongqing Traditional Chinese Medicine No.2 Factory.